PSNC: Shortage of isosorbide mononitrate tablets 10mg, 20mg and 40mg

Source: PSNC Area: News The Pharmaceutical Services Negotiating Committee (PSNC) has re-iterated advice from the Chief Pharmaceutical Officer on the shortage of isosorbide mononitrate tablets (10mg, 20mg and 40mg).   The PSNC has confirmed the following with the Department of Health: "Contractors will be reimbursed for dispensing an unlicensed medicine against prescriptions for all strengths of isosorbide mononitrate (10mg, 20mg and 40mg) tablets.  However, contractors will need to ensure that these prescriptions have been clearly prescribed as "unlicensed" and then endorsed with the actual price paid minus rebates and discounts. The prescriptions should be submitted for payment by placing in the red separator."   PSNC guidance on endorsing unlicensed specials and unlicensed imports can also be accessed via the press release.
Source: NeLM - Cardiovascular Medicine - Category: Cardiology Source Type: news